BACKGROUND Clear cell renal cell carcinoma (ccRCC) is the most common histologically defined renal cancer. However, it is not a uniform disease and includes several genetic subtypes with different prognoses. ccRCC is also characterized by distinctive metabolic reprogramming. Tobacco smoking (TS) is an established risk factor for ccRCC, with unknown effects on tumor pathobiology.METHODS We investigated the landscape of ccRCCs and paired normal kidney tissues using integrated transcriptomic, metabolomic, and metallomic approaches in a cohort of white males who were long-term current smokers (LTS) or were never smokers (NS).RESULTS All 3 Omics domains consistently identified a distinct metabolic subtype of ccRCCs in LTS, characterized by activation of oxidative phosphorylation (OXPHOS) coupled with reprogramming of the malate-aspartate shuttle and metabolism of aspartate, glutamate, glutamine, and histidine. Cadmium, copper, and inorganic arsenic accumulated in LTS tumors, showing redistribution among intracellular pools, including relocation of copper into the cytochrome c oxidase complex. A gene expression signature based on the LTS metabolic subtype provided prognostic stratification of The Cancer Genome Atlas ccRCC tumors that was independent of genomic alterations.CONCLUSION The work identified the TS-related metabolic subtype of ccRCC with vulnerabilities that can be exploited for precision medicine approaches targeting metabolic pathways. The results provided rationale for the development of metabolic biomarkers with diagnostic and prognostic applications using evaluation of OXPHOS status. The metallomic analysis revealed the role of disrupted metal homeostasis in ccRCC, highlighting the importance of studying effects of metals from e-cigarettes and environmental exposures.FUNDING Department of Defense, Veteran Administration, NIH, ACS, and University of Cincinnati Cancer Institute.
James Reigle, Dina Secic, Jacek Biesiada, Collin Wetzel, Behrouz Shamsaei, Johnson Chu, Yuanwei Zang, Xiang Zhang, Nicholas J. Talbot, Megan E. Bischoff, Yongzhen Zhang, Charuhas V. Thakar, Krishnanath Gaitonde, Abhinav Sidana, Hai Bui, John T. Cunningham, Qing Zhang, Laura S. Schmidt, W. Marston Linehan, Mario Medvedovic, David R. Plas, Julio A. Landero Figueroa, Jarek Meller, Maria F. Czyzyk-Krzeska
Title and authors | Publication | Year |
---|---|---|
Identification of metabolic dysregulation and biomarkers for clear cell renal cell carcinoma
Zheng B, Liu K, Ouyang Q, Feng J, Cao S, Wang L, Jia T, Wu S, Ma X, Zhang X, Li X |
Clinical and Translational Medicine | 2024 |
Copper Drives Remodeling of Metabolic State and Progression of Clear Cell Renal Cell Carcinoma
Bischoff ME, Shamsaei B, Yang J, Secic D, Vemuri B, Reisz JA, D\u2019Alessandro A, Bartolacci C, Adamczak R, Schmidt L, Wang J, Martines A, Venkat J, Tcheuyap VT, Biesiada J, Behrmann CA, Vest KE, Brugarolas J, Scaglioni PP, Plas DR, Patra KC, Gulati S, Landero Figueroa JA, Meller J, Cunningham JT, Czyzyk-Krzeska MF |
Cancer Discovery | 2024 |
Modulation of oxidative phosphorylation and mitochondrial biogenesis by cigarette smoke influence the response to immune therapy in NSCLC patients
Wang Y, Smith M, Ruiz J, Liu Y, Kucera GL, Topaloglu U, Chan MD, Li W, Su J, Xing F |
Lung cancer (Amsterdam, Netherlands) | 2023 |
Microtubule-associated protein MAP1LC3C regulates lysosomal exocytosis and induces zinc reprogramming in renal cancer cells.
Verma R, Aggarwal P, Bischoff ME, Reigle J, Secic D, Wetzel C, VandenHeuvel K, Biesiada J, Ehmer B, Landero Figueroa JA, Plas DR, Medvedovic M, Meller J, Czyzyk-Krzeska MF |
The Journal of biological chemistry | 2023 |
Immunometabolic coevolution defines unique microenvironmental niches in ccRCC
Tang C, Xie AX, Liu M, Kuo F, Kim M, Di Natale R, Golkaram M, Chen Y, Gupta S, Motzer R, Russo P, Coleman J, Carlo MI, Voss MH, Kotecha RR, Han Lee C, Tansey W, Schultz N, Hakimi AA, Reznik E |
Cell Metabolism | 2023 |
A novel signature derived from metabolism-related genes GPT and SMS to predict prognosis of laryngeal squamous cell carcinoma.
Shen Y, Huang Q, Zhang Y, Hsueh CY, Zhou L |
Cancer Cell International | 2022 |
Sarcomatoid renal cell carcinoma with clear cells and eosinophilia: a case report and short review of the literature
Neşiu A, Neamţu C, Nicolescu CM, Totolici BD, Mureşanu HD, Roşu MC, Ardelean A, Silivestru VC, Stăniş LA, Marţi TD |
Romanian Journal of Morphology and Embryology | 2022 |
Metabolic subtypes of clear cell renal cell carcinoma defined by tobacco smoking
MF Czyzyk-Krzeska, J Meller, JA Figueroa, DR Plas, JT Cunningham |
Molecular & Cellular Oncology | 2021 |
Molecular and Metabolic Subtypes in Sporadic and Inherited Clear Cell Renal Cell Carcinoma
MF Czyzyk-Krzeska, JA Figueroa, S Gulati, JT Cunningham, J Meller, B ShamsaeI, B Vemuri, DR Plas |
Genes & development | 2021 |
Biomarkers in renal cell carcinoma: Are we there yet?
S Gulati, NJ Vogelzang |
Asian Journal of Urology | 2021 |